Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.

Antonio Gasbarrini, Antonio Grieco, Roberto Cauda, Andrea De Luca, Giuseppe Pastore, Daniele Prati, Francesco Mazzotta, Evangelista Sagnelli, Giampiero Carosi, Nicola Abrescia, Alfredo Alberti, Silvia Ambu, Piero Andreone, Angelo Andriulli, Mario Angelico, Giorgio Antonucci, Antonio Ascione, Luca Saverio Belli, Raffaele Bruno, Savino BrunoPatrizia Burra, Calogero Cammà, Nicola Caporaso, Giuseppe Cariti, Umberto Cillo, Nicola Coppola, Antonio Craxì, Eleonora De Martin, Vito Di Marco, Stefano Fagiuoli, Carlo Ferrari, Giovanni Battista Gaeta, Massimo Galli, Paolo Grossi, Anna Licata, Ivana Maida, Alessandra Mangia, Nicoletta Marino, Renato Maserati, Gabriele Missale, Mario Mondelli, Paola Nasta, Grazia Niro, Marcello Persico, Enzo Petrelli, Antonio Picciotto, Fabio Piscaglia, Teresa Pollicino, Daniele Prati, Claudio Puoti, Massimo Puoti, Giovanni Raimondo, Maria Grazia Rumi, Evangelista Sagnelli, Teresa Santantonio, Antonina Smedile, Giovanni Squadrito, Gianluca Svegliati Baroni, Gloria Taliani, Marcello Tavio, Mario Toti, Ferruccio Bonino, Maurizia Rossana Brunetto, Bruno Cacopardo, Marcello Caremani, Massimo Colombo, Giovanni Di Perri, Francesca Donato, Patrizia Farci, Giovanna Fattovich, Gaetano Filice, Florio Ghinelli, Vincenzo Guadagnino, Adriano Lazzarin, Massimo Levrero, Giuseppe Licata, Anna Orani, Amerigo Paffetti, Felice Piccinino, Eligio Pizzigallo, Patrizia Pontisso, Vincenzo Portelli, Mario Rizzetto, Alessandro Rossi, Tommaso Stroffolini, Enzo Ubaldi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

56 Citazioni (Scopus)

Abstract

It is increasingly clear that a tailored therapeutic approach to patients with hepatitis C virus infection is needed. Success rates in difficult to treat and low-responsive hepatitis C virus patients are not completely satisfactory, and there is the need to optimise treatment duration and intensity in patients with the highest likelihood of response. In addition, the management of special patient categories originally excluded from phase III registration trials needs to be critically re-evaluated. This article reports the recommendations for the treatment of hepatitis C virus infection on an individual basis, drafted by experts of three scientific societies.
Lingua originaleEnglish
pagine (da-a)81-91
Numero di pagine11
RivistaDIGESTIVE AND LIVER DISEASE
Volume2010
Stato di pubblicazionePubblicato - 2010

Keywords

  • guidelines
  • hepatitis c

Fingerprint Entra nei temi di ricerca di 'Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.'. Insieme formano una fingerprint unica.

Cita questo